|
Jun 19
|
QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its Stock
|
|
Jun 19
|
Should You Add NVST Stock to Your Portfolio Right Now?
|
|
Jun 19
|
How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl
|
|
Jun 18
|
Reasons to Add PAHC Stock to Your Portfolio Right Now
|
|
Jun 18
|
Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge?
|
|
Jun 18
|
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)
|
|
Jun 16
|
These 2 Growth Stocks Are No-Brainer Buys Right Now
|
|
Jun 13
|
3 Growth Companies With High Insider Ownership And Up To 27% Earnings Growth
|
|
Jun 12
|
June 2025's Select Stocks That Could Be Trading Below Estimated Value
|
|
Jun 11
|
Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to
|
|
Jun 10
|
Eli Lilly telehealth deals to prevent sale of compounded GLP-1s
|
|
Jun 6
|
The most popular stocks and funds investors bought in May
|
|
May 24
|
Why Hims & Hers Health Stock (HIMS) Is Too Hot to Handle
|
|
May 22
|
Hims & Hers Introduces 6-Month Wegovy® New Customer Offer
|
|
May 22
|
Snowflake stock gains, Nvidia & Navitas, Hims & Hers slips
|
|
May 22
|
Nvidia, Tesla lead over $250 billion in short-seller losses during massive market rally
|
|
Apr 30
|
Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead
|
|
Apr 29
|
Stock Bulls Fuel Best Winning Run Since March 2022: Markets Wrap
|
|
Apr 29
|
Hims Stock Catapults After Inking Deal To Sell Novo Nordisk's Wegovy
|
|
Apr 29
|
Hims-Novo Nordisk partnership, SoFi earnings, Spotify guidance
|